会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 82. 发明公开
    • METHOD OF PRODUCING PARTIALLY PURIFIED EXTRACELLULAR METABOLITE PRODUCTS FROM BACILLUS COAGULANS AND BIOLOGICAL APPLICATIONS THEREOF
    • 用于生产部分纯化的胞外METABOLITPRODUKTEN从凝结芽孢杆菌与生物它们的应用
    • EP2989197A1
    • 2016-03-02
    • EP14873856.0
    • 2014-12-24
    • Majeed, Muhammed
    • NAGABHUSHANAM, KalyanamARUMUGAM, SivakumarALI, Furqan
    • C12N1/20
    • A01N63/02A01N31/08A01N37/12C12N1/20C12R1/07C12R1/085C12R1/19C12R1/385C12R1/42C12R1/445C12R1/45C12R1/46A01N65/08
    • Disclosed is a method for producing partially purified extracellular metabolite preparation from the probiotic bacterial strain Bacillus coagulans SBC-37 (Deposited in the Microbial Type Culture Collection and Gene Bank as strain number MTCC 5856) exhibiting 99% genetic homology with the known bacterial strains Bacillus coagulans ATCC 31284, Bacillus coagulans NBRC 3887 and Bacillus coagulans ATCC 7050. Also disclosed is the anti-microbial profile of said extracellular metabolite preparation against a panel of microbial pathogens, including synergistic anti-microbial effects of preparation when combined with a synergistic preservative blend comprising from about 61% w/w of thymol, about 38% of monolaurin and about 1% w/w of magnolol obtained from supercritical fluid extracts of Magnolia officinalis. The extracellular metabolite preparation alone or the combination of said extracellular metabolite preparation and preservative blend also inhibits microbial biofilm formation in a synergistic manner.
    • 公开了一种用于从益生菌菌株凝结芽孢杆菌SBC-37(在微生物典型培养物保藏中心和基因库保藏为菌株号MTCC 5856)参展99%的遗传同源性与已知的细菌菌株凝结芽孢杆菌生产的部分纯化的细胞外代谢物制备方法 ATCC 31284,凝结芽孢杆菌NBRC 3887和凝结芽孢杆菌ATCC 7050所以盘游离缺失是针对微生物病原体,包括准备的协同抗微生物作用时具有协同防腐剂共混物由包含组合的面板。所述胞外代谢物制剂的抗微生物轮廓 约61%w / w的百里酚,单月桂酸甘油酯的约38%至约1%w / w的厚朴酚从厚朴超临界流体提取物中得到。 所以单独的胞外代谢物制剂或所述胞外代谢物的制备和防腐剂共混物的组合抑制以协同方式微生物生物膜的形成。